Evidence map›Paper›PMID 40977807›Full record

ArticleFrontiers in public health2025

The effects of the diagnosis-intervention packet payment reform in China: evidence from Guangzhou.

Yuhao Wang, Xiaoqing Huang, Nana Lu, Xin Xu, Lina Wang, Wenwen Du, Wei Xu

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuhao WangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Xiaoqing HuangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Nana LuZhongda Hospital, Southeast University, Nanjing, China.
Xin XuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Lina WangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Wenwen DuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Wei XuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study evaluated the impact of Guangzhou's Diagnosis-Intervention Packet (DIP) payment reform, introduced as an alternative to the traditional fee-for-service (FFS) model, on inpatient costs, patients' out-of-pocket (OOP) payments, hospital length of stay (LOS) and 30-day readmission rate. Method: We conducted a single-group interrupted time series analysis using monthly data from the Guangzhou Urban Employee Basic Medical Insurance Scheme, spanning January 2017 to June 2020. Outcome indicators included inpatient cost per case, medication expenditures, medical consumables expenditures, diagnostic and therapeutic service expenditures, OOP payments, LOS and 30-day readmission rate. Results: While the DIP reform was associated with a modest reduction in the rate of LOS decline, it did not significantly lower inpatient cost. Instead, total inpatient expenditures exhibited a sustained upward trend in the post-reform period. Moreover, OOP payments per case increased significantly following the reform, indicating a heavier financial burden on patients. Sub-item analysis revealed that medication expenditures declined and stabilized after a pre-policy drop, whereas diagnostic and therapeutic service expenditures continued to grow without evident signs of deceleration. The 30-day readmission rate remained largely stable throughout the study period. Conclusion: The DIP reform in Guangzhou did not achieve its intended goals of reducing inpatient expenditures or alleviating patients' financial burdens. These unintended effects were driven by the incentive structure of the DIP system-particularly its reliance on historical cost data for RW calculation and its reimbursement deduction method-which encouraged hospitals to shift costs and elevate OOP payments. Policymakers should reassess DIP's algorithmic parameters and strengthen cost-accounting transparency to ensure more equitable and efficient medical insurance fund allocation.

Indexed as

Health Care ReformHealth ExpendituresChinaFee-for-Service PlansHumansInterrupted Time Series AnalysisLength of StayPatient ReadmissionDIP payment reforminpatient costsinterrupted time series analysisout-of-pocket paymentspolicy evaluation

Identifiers

PMID40977807
PMCPMC12446326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.